• 1. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 2. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Sulfanilides

Recent Advances in the Study of 2-(4-Fluorobenzenesulfonamido)benzoic Acid (CAS: 51012-30-7)

The compound 2-(4-fluorobenzenesulfonamido)benzoic acid (CAS: 51012-30-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This sulfonamide derivative, characterized by its unique structural features, has shown promising potential in various therapeutic applications. Recent studies have focused on its synthesis, mechanism of action, and biological activities, particularly in the context of anti-inflammatory and anticancer properties. This research brief aims to summarize the latest findings and highlight the compound's potential as a lead molecule for drug development.

One of the key areas of investigation has been the synthesis and optimization of 2-(4-fluorobenzenesulfonamido)benzoic acid. Researchers have developed novel synthetic routes to improve yield and purity, which are critical for its pharmaceutical applications. Advanced techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to characterize the compound and ensure its structural integrity. These efforts have paved the way for more detailed pharmacological studies.

In terms of biological activity, recent studies have demonstrated that 2-(4-fluorobenzenesulfonamido)benzoic acid exhibits potent anti-inflammatory effects by inhibiting key enzymes involved in the inflammatory cascade, such as cyclooxygenase-2 (COX-2). This mechanism is similar to that of nonsteroidal anti-inflammatory drugs (NSAIDs), but with potentially fewer side effects due to its selective inhibition. Additionally, the compound has shown promising results in preclinical models of cancer, where it has been found to induce apoptosis in certain cancer cell lines, suggesting its potential as an anticancer agent.

Another significant aspect of the research has been the exploration of the compound's pharmacokinetic properties. Studies have investigated its absorption, distribution, metabolism, and excretion (ADME) profiles to better understand its behavior in biological systems. These findings are crucial for the development of formulations that can enhance its bioavailability and therapeutic efficacy. Preliminary data indicate that 2-(4-fluorobenzenesulfonamido)benzoic acid has favorable pharmacokinetic characteristics, making it a viable candidate for further development.

Despite these promising findings, challenges remain in the clinical translation of 2-(4-fluorobenzenesulfonamido)benzoic acid. Issues such as solubility, stability, and potential toxicity need to be addressed through further research. However, the compound's unique structural and functional properties make it a compelling subject for ongoing studies. Future research directions may include the development of derivatives with enhanced activity and reduced side effects, as well as the exploration of its potential in combination therapies.

In conclusion, 2-(4-fluorobenzenesulfonamido)benzoic acid (CAS: 51012-30-7) represents a promising molecule in the field of chemical biology and pharmaceutical research. Its demonstrated anti-inflammatory and anticancer activities, coupled with favorable pharmacokinetic properties, highlight its potential as a lead compound for drug development. Continued research efforts will be essential to fully realize its therapeutic potential and address the remaining challenges in its clinical application.

• 777897-67-3(2-fluoro-6-{[(4-methylphenyl)sulfonyl]amino}benzoic acid)
• 379254-41-8(2-(4-fluoro-3-methylbenzenesulfonamido)benzoic acid)
• 392313-12-1(4-(4-Fluorobenzenesulfonamido)Benzoic Acid)
• 530-73-4( )
• 138964-56-4(2-benzenesulfonamido-5-methylbenzoic acid)
• 663595-41-3(Benzoic acid, 2-[[(3-fluorophenyl)sulfonyl]amino]-, methyl ester)
• 721406-27-5(3-(4-Fluorobenzenesulfonamido)-4-Methylbenzoic Acid)
• 329941-52-8(2-(4-Fluoro-benzenesulfonylamino)-terephthalic acid dimethyl ester)
• 6311-23-5(2-(4-methylbenzenesulfonamido)benzoic acid)
• 330467-30-6(methyl 2-(4-fluorobenzenesulfonamido)benzoate)